Abstract
Background
The analgesic effect and postoperative effects of esketamine are not yet clear in bariatric surgeries. Many bariatric surgery patients suffer from acute abdominal pain after surgery which leads to increased opioid use. This study aimed to determine whether intraoperative use of esketamine could reduce acute postoperative pain in bariatric surgery patients.
Methods
We designed a randomized double-blinded controlled trial. Included patients between the ages of 18 and 50 years with a body mass index ≥27 kg/m2 and American Society of Anesthesiologists Physical Status of I-III, scheduled to undergo sleeve gastrectomy. We divided them into two groups, the control group which received a placebo, and the esketamine group which received a loading dose of esketamine 0.2 mg/kg and a maintenance dose of 0.2 mg/(kg·h) along with other anesthetic drugs during the surgery. After the surgery, they were assessed for Numerical Rating Scale (NRS) pain scores and Post Operative Nausea and Vomiting (PONV) scores, while other surgical data were recorded during the surgery.
Results
We enrolled 68 patients, 52 females, and 16 males. The 0.5 h, 1 h, 2 h, 6 h, and 12 h NRS scores were significantly lower in the esketamine group compared to the control group, and the extra painkillers administered were significantly lower in the esketamine group (p<0.05).
Conclusion
Intraoperative use of esketamine can reduce acute postoperative pain in bariatric surgery patients. Further studies should explore whether the reduced pain is due to the anti-depressive effect of esketamine or purely the analgesic effect.
Trial registration
Chinese Clinical Trial Registry (ChiCTR2100054038, https://www.chictr.org.cn/com/25/showproj.aspx?proj=142806)
Graphical Abstract
Similar content being viewed by others
References
Hamp T, Baron-Stefaniak J, Krammel M, et al. Effect of intravenous S-ketamine on the MAC of sevoflurane: a randomised, placebo-controlled, double-blinded clinical trial. Br J Anaesth. 2018;121(6):1242–8.
Chen L, He W, Liu X, et al. Application of opioid-free general anesthesia for gynecological laparoscopic surgery under ERAS protocol: a non-inferiority randomized controlled trial. BMC Anesthesiol. 2023;23(1):34.
Chen HY, Meng XY, Gao H, et al. Esketamine-based opioid-free anaesthesia alleviates postoperative nausea and vomiting in patients who underwent laparoscopic surgery: study protocol for a randomized, double-blinded, multicentre trial. Trials. 2023;24(1):13.
Zhu M, Xu S, Ju X, et al. Effects of the different doses of esketamine on postoperative quality of recovery in patients undergoing modified radical mastectomy: a randomized, double-blind, controlled trial. Drug Des Devel Ther. 2022;16:4291–9.
Yuan JJ, Chen SH, Xie YL, et al. Effects of subanesthetic dose of esketamine on opioid consumption after thoracoscopic surgery. Zhonghua Yi Xue Za Zhi. 2022;102(15):1108–13.
Wang J, Hu W, Zhao X, et al. Sedative effect and safety of different doses of S-ketamine in combination with propofol during gastro-duodenoscopy in school-aged children: a prospective, randomized study. BMC Anesthesiol. 2022;22(1):346.
Xin N, Yan W, Jin S. Efficacy of analgesic propofol/esketamine and propofol/fentanyl for painless induced abortion: a randomized clinical trial. Biomed Res Int. 2022;2022:5095282.
Castagneto-Gissey L, Casella-Mariolo J, Mingrone G. Bariatric/metabolic surgery. Handb Exp Pharmacol. 2022;274:371–86.
Iamaroon A, Tangwiwat S, Nivatpumin P, et al. Risk factors for moderate to severe pain during the first 24 hours after laparoscopic bariatric surgery while receiving intravenous patient-controlled analgesia. Anesthesiol Res Pract. 2019;2019:6593736.
Pirie K, Traer E, Finniss D, et al. Current approaches to acute postoperative pain management after major abdominal surgery: a narrative review and future directions. Br J Anaesth. 2022;129(3):378–93.
Simoni AH, Ladebo L, Christrup LL, et al. Chronic abdominal pain and persistent opioid use after bariatric surgery. Scand J Pain. 2020;20(2):239–51.
Bahji A, Vazquez GH, Zarate Jr CA. Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis. J Affect Disord. 2021;278:542–55.
Eipe N, Budiansky AS. Perioperative pain management in bariatric anesthesia. Saudi J Anaesth. 2022;16(3):339–46.
McIntyre RS, Rosenblat JD, Nemeroff CB, et al. Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry. 2021;178(5):383–99.
Kane SP. Sample size calculator. ClinCalc LLC; [cited 2023]; Available from: https://clincalc.com/Stats/SampleSize.aspx.
Wang Y, Gao Y, Ma J. Pleiotropic effects and pharmacological properties of penehyclidine hydrochloride. Drug Des Devel Ther. 2018;12:3289–99.
Ye RR, Jiang S, Xu X, et al. Dezocine as a potent analgesic: overview of its pharmacological characterization. Acta Pharmacol Sin. 2022;43(7):1646–57.
Folino TB, Muco E, Safadi AO, et al. Propofol. [Updated 2022 Jul 25]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995;83(5):968–75.
Bovill JG, Sebel PS, Blackburn CL, et al. The pharmacokinetics of sufentanil in surgical patients. Anesthesiology. 1984;61(5):502–6.
Bahr R, Lopez A, Rey JA. Intranasal esketamine (Spravato(TM)) for use in treatment-resistant depression in conjunction with an oral antidepressant. Pharmacol Ther. 2019;44(6):340–75.
Frauenknecht J, Kirkham KR, Jacot-Guillarmod A, et al. Analgesic impact of intra-operative opioids vs. opioid-free anaesthesia: a systematic review and meta-analysis. Anaesthesia. 2019;74(5):651–62.
Li J, Wang Z, Wang A, et al. Clinical effects of low-dose esketamine for anaesthesia induction in the elderly: a randomized controlled trial. J Clin Pharm Ther. 2022;47(6):759–66.
Zhang C, He J, Shi Q, et al. Subanaesthetic dose of esketamine during induction delays anaesthesia recovery a randomized, double-blind clinical trial. BMC Anesthesiol. 2022;22(1):138.
Guo Y, Chen L, Gao Z, et al. Is esketamine-based opioid-free anesthesia more superior for postoperative analgesia in obstructive sleep apnea patients undergoing bariatric surgery? A study protocol. Front Med. 2022;9:1039042.
Tighe PJ, Riley 3rd JL, Fillingim RB. Sex differences in the incidence of severe pain events following surgery: a review of 333,000 pain scores. Pain Med. 2014;15(8):1390–404.
Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO global registry report 2018. Obes Surg. 2019;29(3):782–95.
Data Access Statement
Supplementary data can be accessed online at https://doi.org/10.17632/cxtkvr786g.1.
Funding
This work was supported by the Sichuan Informatics Association of Tradition Chinese Medicine [5101075642792].
Author information
Authors and Affiliations
Contributions
T.Y. designed the study, collected the data, and wrote the manuscript. M.S.M. wrote the manuscript and analyzed the data. M.X.X. collected the data. B.L. and Q.F. supervised the study. T.Y. and M.S.M. have contributed equally to this work.
Corresponding author
Ethics declarations
Human and Animal Rights/Ethical Approval
This study was approved by the Ethics Committee of Chengdu Third People’s Hospital (approval number 713, 2021).
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• Esketamine can reduce acute postoperative pain in bariatric surgery patients.
• Use of extra painkillers in the ICU for the first 48 h was significantly lower.
• Intraoperative esketamine did not cause any adverse side effects at 0.2 mg/(kg·h).
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yang, T., Mudabbar, M.S., Liu, B. et al. Intraoperative Esketamine Is Effective at Reducing Acute Postoperative Pain in Bariatric Surgery Patients: a Randomized Control Trial. OBES SURG 33, 2368–2374 (2023). https://doi.org/10.1007/s11695-023-06676-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-06676-2